These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21468051)

  • 21. Prediction of individual genetic risk to prostate cancer using a polygenic score.
    Szulkin R; Whitington T; Eklund M; Aly M; Eeles RA; Easton D; Kote-Jarai ZS; Amin Al Olama A; Benlloch S; Muir K; Giles GG; Southey MC; Fitzgerald LM; Henderson BE; Schumacher F; Haiman CA; Schleutker J; Wahlfors T; Tammela TL; Nordestgaard BG; Key TJ; Travis RC; Neal DE; Donovan JL; Hamdy FC; Pharoah P; Pashayan N; Khaw KT; Stanford JL; Thibodeau SN; McDonnell SK; Schaid DJ; Maier C; Vogel W; Luedeke M; Herkommer K; Kibel AS; Cybulski C; Lubiński J; Kluźniak W; Cannon-Albright L; Brenner H; Butterbach K; Stegmaier C; Park JY; Sellers T; Lin HY; Slavov C; Kaneva R; Mitev V; Batra J; Clements JA; ; Spurdle A; Teixeira MR; Paulo P; Maia S; Pandha H; Michael A; Kierzek A; ; Gronberg H; Wiklund F
    Prostate; 2015 Sep; 75(13):1467-74. PubMed ID: 26177737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.
    Manchanda R; Legood R; Burnell M; McGuire A; Raikou M; Loggenberg K; Wardle J; Sanderson S; Gessler S; Side L; Balogun N; Desai R; Kumar A; Dorkins H; Wallis Y; Chapman C; Taylor R; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
    J Natl Cancer Inst; 2015 Jan; 107(1):380. PubMed ID: 25435542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinically relevant changes in family history of cancer over time.
    Ziogas A; Horick NK; Kinney AY; Lowery JT; Domchek SM; Isaacs C; Griffin CA; Moorman PG; Edwards KL; Hill DA; Berg JS; Tomlinson GE; Anton-Culver H; Strong LC; Kasten CH; Finkelstein DM; Plon SE
    JAMA; 2011 Jul; 306(2):172-8. PubMed ID: 21750294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening.
    So HC; Kwan JS; Cherny SS; Sham PC
    Am J Hum Genet; 2011 May; 88(5):548-65. PubMed ID: 21529750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer risk prediction using a polygenic risk score.
    Sipeky C; Talala KM; Tammela TLJ; Taari K; Auvinen A; Schleutker J
    Sci Rep; 2020 Oct; 10(1):17075. PubMed ID: 33051487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are we ready for the challenge of implementing risk-based breast cancer screening and primary prevention?
    Rainey L; van der Waal D; Jervaeus A; Wengström Y; Evans DG; Donnelly LS; Broeders MJM
    Breast; 2018 Jun; 39():24-32. PubMed ID: 29529454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening.
    Eriksson M; Czene K; Strand F; Zackrisson S; Lindholm P; Lång K; Förnvik D; Sartor H; Mavaddat N; Easton D; Hall P
    Radiology; 2020 Nov; 297(2):327-333. PubMed ID: 32897160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer.
    Bancroft EK; Castro E; Bancroft GA; Ardern-Jones A; Moynihan C; Page E; Taylor N; Eeles RA; Rowley E; Cox K
    Psychooncology; 2015 Nov; 24(11):1492-9. PubMed ID: 25872100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporating genomics into breast and prostate cancer screening: assessing the implications.
    Chowdhury S; Dent T; Pashayan N; Hall A; Lyratzopoulos G; Hallowell N; Hall P; Pharoah P; Burton H
    Genet Med; 2013 Jun; 15(6):423-32. PubMed ID: 23412607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer.
    Koitsalu M; Sprangers MA; Eklund M; Czene K; Hall P; Grönberg H; Brandberg Y
    Acta Oncol; 2016; 55(1):45-51. PubMed ID: 25990635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement.
    Darabi H; Czene K; Zhao W; Liu J; Hall P; Humphreys K
    Breast Cancer Res; 2012 Feb; 14(1):R25. PubMed ID: 22314178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
    Lindström S; Schumacher FR; Cox D; Travis RC; Albanes D; Allen NE; Andriole G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Crawford ED; Diver WR; Gaziano JM; Giles GG; Giovannucci E; Gonzalez CA; Henderson B; Hunter DJ; Johansson M; Kolonel LN; Ma J; Le Marchand L; Pala V; Stampfer M; Stram DO; Thun MJ; Tjonneland A; Trichopoulos D; Virtamo J; Weinstein SJ; Willett WC; Yeager M; Hayes RB; Severi G; Haiman CA; Chanock SJ; Kraft P
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):437-44. PubMed ID: 22237985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Envisioning Implementation of a Personalized Approach in Breast Cancer Screening Programs: Stakeholder Perspectives.
    Esquivel-Sada D; Lévesque E; Hagan J; Knoppers BM; Simard J
    Healthc Policy; 2019 Nov; 15(2):39-54. PubMed ID: 32077844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.
    Hugosson J; Carlsson S; Aus G; Bergdahl S; Khatami A; Lodding P; Pihl CG; Stranne J; Holmberg E; Lilja H
    Lancet Oncol; 2010 Aug; 11(8):725-32. PubMed ID: 20598634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoporosis screening using computed tomography for men with prostate cancer: results of a prospective study.
    McDonald AM; Yang ES; Saag KG; Levitan EB; Wright NC; Fiveash JB; Rais-Bahrami S; Bhatia S
    Arch Osteoporos; 2020 Feb; 15(1):32. PubMed ID: 32112196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population screening for prostate cancer and emerging concepts for young men.
    Moul JW
    Clin Prostate Cancer; 2003 Sep; 2(2):87-97. PubMed ID: 15040869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common breast cancer risk alleles and risk assessment: a study on 35 441 individuals from the Danish general population.
    Näslund-Koch C; Nordestgaard BG; Bojesen SE
    Ann Oncol; 2017 Jan; 28(1):175-181. PubMed ID: 28177461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
    Shieh Y; Eklund M; Madlensky L; Sawyer SD; Thompson CK; Stover Fiscalini A; Ziv E; Van't Veer LJ; Esserman LJ; Tice JA;
    J Natl Cancer Inst; 2017 Jan; 109(5):. PubMed ID: 28130475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification.
    Läll K; Lepamets M; Palover M; Esko T; Metspalu A; Tõnisson N; Padrik P; Mägi R; Fischer K
    BMC Cancer; 2019 Jun; 19(1):557. PubMed ID: 31182048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological impact of providing women with personalised 10-year breast cancer risk estimates.
    French DP; Southworth J; Howell A; Harvie M; Stavrinos P; Watterson D; Sampson S; Evans DG; Donnelly LS
    Br J Cancer; 2018 Jun; 118(12):1648-1657. PubMed ID: 29736008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.